Skip to Content

Minocycline topical Pregnancy and Breastfeeding Warnings

Minocycline topical is also known as: Arestin

Medically reviewed on June 1, 2017

Minocycline topical Pregnancy Warnings

Minocycline topical powder has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of embryo and fetotoxicity. There are no controlled data in human pregnancy. However, there have been reports of congenital defects associated with the tetracycline class of antibiotics. Minocycline topical should only be given during pregnancy when benefit outweighs risk.

See references

Minocycline topical Breastfeeding Warnings

Minocycline is excreted into human milk. Theoretical risks of dental staining and inhibition of bone growth exist but are unlikely. Tetracycline, a related drug, is considered compatible with breast-feeding by the American Academy of Pediatrics.

See references

References for pregnancy information

  1. "Product Information. Arestin (minocycline topical)" OraPharma, Inc, Warminster, PA.
  2. "Product Information. Minocin (minocycline)." Lederle Laboratories, Wayne, NJ.

References for breastfeeding information

  1. "Product Information. Arestin (minocycline topical)" OraPharma, Inc, Warminster, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide